Health Care [ 4/12 ] | Pharmaceuticals [ 14/72 ]
NASDAQ | Common Stock
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines.
The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate.
Milestone Pharmaceuticals Inc. has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans.
The company was incorporated in 2003 and is headquartered in Montréal, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jun 13, 24 | -0.21 Increased by +40.00% | -0.26 Increased by +19.23% |
| Mar 21, 24 | -0.32 Decreased by -3.23% | -0.31 Decreased by -3.23% |
| Nov 13, 23 | -0.35 Decreased by -2.94% | -0.38 Increased by +7.89% |
| Aug 10, 23 | -0.37 Increased by +5.13% | -0.39 Increased by +5.13% |
| May 11, 23 | -0.35 Decreased by -6.06% | -0.40 Increased by +12.50% |
| Mar 29, 23 | -0.31 Increased by +22.50% | -0.33 Increased by +6.06% |
| Nov 10, 22 | -0.34 Increased by 0.00% | -0.41 Increased by +17.07% |
| Aug 10, 22 | -0.39 Decreased by -2.05 K% | -0.36 Decreased by -8.33% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 0.00 Decreased by -100.00% | -15.08 M Decreased by -7.09% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -16.04 M Increased by +2.71% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 1.00 M Increased by +N/A% | -14.40 M Decreased by -3.09% | Decreased by -1.44 K% Decreased by N/A% |
| Dec 31, 22 | 3.50 M Decreased by -76.67% | 18.26 M Increased by +208.14% | Increased by +521.66% Increased by +563.45% |
| Sep 30, 22 | 1.50 M Decreased by -90.00% | -14.08 M Increased by +1.01% | Decreased by -938.80% Decreased by -889.95% |
| Jun 30, 22 | 0.00 Decreased by -100.00% | -16.49 M Decreased by -2.24 K% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -13.97 M Decreased by -11.61% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 15.00 M Increased by +N/A% | -16.88 M Decreased by -94.83% | Decreased by -112.56% Decreased by N/A% |